Ozempic FDA Approval and Intended Use Saxenda: FDA-approved specifically for weight management in adults and adolescents (1217 years) with obesity or weight-related health conditions
investigational since 1995 Original developer / Merck Research Laboratories Mechanism / GHS-R1a agonist mimicking acyl-ghrelin binding Key pharmacokinetic advantage / oral bioavailability with 24-hour GH pulsatility IGF-1 elevation / sustained 40-60% increase at 25 mg daily over 12 months Primary safety signal / insulin resistance, edema, appetite stimulation Active clinical space / sarcopenia, frailty, GH deficiency alternatives Pipeline competitors / anamorelin (approved in Japan), macimorelin (FDA-approved diagnostic) Reformulation interest / transdermal, sustained-release, and receptor-biased analogs How MK-677 Works: The Mechanism Behind Pipeline Interest MK-677 activates the growth hormone secretagogue receptor (GHS-R1a), the same receptor bound by endogenous ghrelin
Wegovy is a brand name for semaglutide, an injectable drug for weight loss that acts as a glucagon-like peptide-1 (GLP-1) receptor agonist
May 2 2013;147(1):245-53
10.1038/jhg.2016.20 19
Chemical Modulation Strategy Chemical modification, like PEGylation, enhances bioavailability of therapeutic peptides and proteins while preserving their pharmacological potency
